Development and validation of a prediction model for cardiovascular–kidney–metabolic syndrome progression: a multicenter study
Open Access
- 19 March 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 13, 1783262
Abstract
Background: Dysfunction of multiple systems significantly contributes to cardiovascular–kidney–metabolic syndrome (CKM). We aimed to use routine indicators to predict progression to CKM and to examine the influence of the liver metabolic axis on CKM progression. Methods: This study was a multicenter retrospective study. We developed a model using new lipid-metabolism indicators to predict progression to CKM. Model performance was evaluated using discrimination, calibration, and decision curve analysis (DCA). Further studies on patients with diabetes and metabolic dysfunction-associated steatotic liver disease (MASLD) explored the link to CKM progression. Results: A total of 21,026 participants with CKM stages 1 or 2 at baseline. The model demonstrated robust discrimination, with AUCs of 0.718 (95% CI 0.704–0.730) in the 2016–2019 cohort, 0.727 (95% CI 0.714–0.740) in the 2020 cohort, and 0.747 (95% CI 0.711–0.777) in the 2021 validation cohort. The predicted-risk quartiles were 1.8, 7.6, 11.4, and 24.9%, respectively. Subgroup analyses confirmed stable discrimination across clinical subgroups and different centers. Exploratory analyses revealed that individuals with diabetes and MASLD had the highest risk of CKM progression (odds ratio [OR] 2.13, 95% CI 1.89–2.40). Conclusion: We developed a reliable model that identifies individuals at risk of progressing to CKM in the real world. Our results also suggest the liver metabolism axis may be crucial in CKM deterioration.Keywords
This publication has 31 references indexed in Scilit:
- Cardiovascular Indexes and Oxidative Balance in Advanced Cardiovascular–Kidney–Metabolic SyndromeObesity, 2025
- Divergent impacts of air pollution on cardiovascular-kidney-metabolic progression: Comparative evidence from Chinese vs. British cohortsJournal of Hazardous Materials, 2025
- Depression severity as a predictor of cardiovascular-kidney-metabolic syndrome progression and mortality: Results from two nationally representative cohort studiesJournal of Affective Disorders, 2025
- External Validation of the American Heart Association PREVENT Cardiovascular Disease Risk EquationsJAMA Network Open, 2024
- Association between different stages of cardiovascular-kidney-metabolic syndrome and the risk of all-cause mortalityAtherosclerosis, 2024
- EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)Journal of Hepatology, 2024
- Cardiovascular-kidney-metabolic syndrome: A step toward multidisciplinary and inclusive careCell Metabolism, 2023
- Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney diseaseNature Reviews Nephrology, 2023
- The metabolic syndrome and chronic kidney diseaseTranslational Research, 2017
- A simulation study of the number of events per variable in logistic regression analysisJournal of Clinical Epidemiology, 1996